Sumner leads the AstraZeneca US Access Services and Reimbursement team that provides patient and provider access, affordability, reimbursement, and clinical services for the AstraZeneca portfolio of medicines across the oncology, cardiovascular, renal & metabolic, and respiratory & immunology therapeutic areas. Prior to AstraZeneca, Sumner served in various operations, strategy, and business development roles at Covance Market Access Services Inc. He has 19 years of specialty pharmaceutical market access industry experience supporting 25 medicines, 15 specialty drug launches, spanning 18 disease states. Sumner has a passion for leading organizations to continuously innovate operating models, technology ecosystems, and market access and reimbursement strategies to ensure patients and providers can benefit from the novel science delivered by the life sciences industry. Sumner holds a Bachelor’s of Science in Biology degree from Hampton University.